Latest Iron Triangle Partners LP Stock Portfolio

Iron Triangle Partners LP Performance:

2025 Q3: 5.98%YTD: 8.08%2024: 9.42%

Performance for 2025 Q3 is 5.98%, and YTD is 8.08%, and 2024 is 9.42%.

About Iron Triangle Partners LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Iron Triangle Partners LP reported an equity portfolio of $703.3 Millions as of 30 Sep, 2025.

The top stock holdings of Iron Triangle Partners LP are CVS, DXCM, ABBV. The fund has invested 8.6% of it's portfolio in CVS HEALTH CORP and 8.1% of portfolio in DEXCOM INC.

The fund managers got completely rid off MERIT MED SYS INC (MMSI), ICON PLC and INTUITIVE SURGICAL INC (ISRG) stocks. They significantly reduced their stock positions in DOXIMITY INC (DOCS), ARGENX SE and TENET HEALTHCARE CORP (THC). Iron Triangle Partners LP opened new stock positions in DEXCOM INC (DXCM), ELI LILLY & CO (LLY) and REPLIGEN CORP (RGEN). The fund showed a lot of confidence in some stocks as they added substantially to BROOKDALE SR LIVING INC (BKD), EXACT SCIENCES CORP (EXAS) and GUARDANT HEALTH INC (GH).

Iron Triangle Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that Iron Triangle Partners LP made a return of 5.98% in the last quarter. In trailing 12 months, it's portfolio return was 9.38%.

Performance
S&P 500

New Buys

Ticker	$ Bought
dexcom inc	57,196,500
eli lilly & co	37,810,500
repligen corp	36,090,900
madrigal pharmaceuticals inc	26,775,700
jazz pharmaceuticals plc	19,770,000
neurocrine biosciences inc	18,444,500
west pharmaceutical svsc inc	18,363,100
veracyte inc	16,650,000

New stocks bought by Iron Triangle Partners LP

Additions

Ticker	% Inc.
brookdale sr living inc	66.96
exact sciences corp	66.67
guardant health inc	33.33
cardinal health inc	31.12
glaukos corp	26.42
adaptive biotechnologies cor	21.73
medtronic plc	13.34
cvs health corp	6.39

Additions to existing portfolio by Iron Triangle Partners LP

Reductions

Ticker	% Reduced
doximity inc	-55.44
argenx se	-36.4
tenet healthcare corp	-27.66
abbvie inc	-19.87
charles riv labs intl inc	-16.25

Iron Triangle Partners LP reduced stake in above stock

Sold off

Ticker	$ Sold
enhabit inc	-9,909,650
envista holdings corporation	-12,114,800
twist bioscience corp	-15,612,000
merit med sys inc	-36,717,400
icon plc	-36,362,500
hca healthcare inc	-30,648,000
insmed inc	-7,044,800
insulet corp	-21,377,100

Iron Triangle Partners LP got rid off the above stocks

Sector Distribution

Iron Triangle Partners LP has about 93.8% of it's holdings in Healthcare sector.

Sector	%
Healthcare	93.8
Others	6.2

Market Cap. Distribution

Iron Triangle Partners LP has about 57% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	45
MID-CAP	24.7
SMALL-CAP	12.1
MEGA-CAP	12
UNALLOCATED	6.2

Stocks belong to which Index?

About 73.2% of the stocks held by Iron Triangle Partners LP either belong to S&P 500 or RUSSELL 2000 index.

Index	%
S&P 500	46.5
Others	26.9
RUSSELL 2000	26.7

Top 5 Winners (%)		%
	argenx se	27.6 %
ADPT	adaptive biotechnologies cor	25.2 %
	brightspring health svcs inc	24.8 %
ABBV	abbvie inc	22.3 %
GH	guardant health inc	17.1 %

Top 5 Winners ($)		$
ABBV	abbvie inc	10.3 M
	brightspring health svcs inc	7.3 M
ADPT	adaptive biotechnologies cor	5.5 M
CVS	cvs health corp	5.0 M
THC	tenet healthcare corp	4.4 M

Top 5 Losers (%)		%
GKOS	glaukos corp	-19.3 %
CAH	cardinal health inc	-5.8 %
AHCO	adapthealth corp	-5.1 %

Top 5 Losers ($)		$
GKOS	glaukos corp	-6.7 M
CAH	cardinal health inc	-1.3 M
AHCO	adapthealth corp	-0.9 M

Iron Triangle Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Iron Triangle Partners LP

Iron Triangle Partners LP has 25 stocks in it's portfolio. About 59% of the portfolio is in top 10 stocks. GKOS proved to be the most loss making stock for the portfolio. ABBV was the most profitable stock for Iron Triangle Partners LP last quarter.

Last Reported on: 14 Nov, 2025

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ABBV	abbvie inc	6.60	200,326	46,383,500	reduced	-19.87

ADPT	adaptive biotechnologies cor	3.87	1,820,920	27,240,900	added	21.73

AHCO	adapthealth corp	2.45	1,924,130	17,221,000	added	0.21

ALNY	alnylam pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

BGNE	beone medicines ltd	0.00	0.00	0.00	sold off	-100

BKD	brookdale sr living inc	3.42	2,838,360	24,040,900	added	66.96

CAH	cardinal health inc	3.08	138,011	21,662,200	added	31.12

CRL	charles riv labs intl inc	5.96	268,000	41,931,300	reduced	-16.25

CVS	cvs health corp	8.55	797,900	60,153,700	added	6.39

DOCS	doximity inc	2.18	210,000	15,361,500	reduced	-55.44

DXCM	dexcom inc	8.13	850,000	57,196,500	new

EHAB	enhabit inc	0.00	0.00	0.00	sold off	-100

EXAS	exact sciences corp	3.89	500,000	27,355,000	added	66.67

FOLD	amicus therapeutics inc	2.21	1,971,260	15,533,500	new

GH	guardant health inc	3.55	400,000	24,992,000	added	33.33

GKOS	glaukos corp	3.98	342,804	27,955,700	added	26.42

HCA	hca healthcare inc	0.00	0.00	0.00	sold off	-100

IDYA	ideaya biosciences inc	1.04	270,000	7,346,700	new

INSM	insmed inc	0.00	0.00	0.00	sold off	-100

ISRG	intuitive surgical inc	0.00	0.00	0.00	sold off	-100